Literature DB >> 30485538

Parathyroidectomy decreases serum intact parathyroid hormone and calcium levels and prolongs overall survival in elderly hemodialysis patients with severe secondary hyperparathyroidism.

Jinnan Wan1, Wenhuan Li1, Yuan Zhong1.   

Abstract

BACKGROUND: The objective of this study was to assess the effect of parathyroidectomy (PTX) treatment on prolonging overall survival (OS) as well as decreasing levels of intact parathyroid hormone (iPTH), calcium (Ca), and phosphorus (P) in elderly hemodialysis patients with severe secondary hyperparathyroidism (SHPT).
METHODS: A total of 304 elderly hemodialysis patients with severe SHPT were consecutively enrolled in this cohort study. According to whether PTX operations were applied, patients were classified into PTX group (N = 112) and Control group (N = 192) and were followed up for 3 years. Mortality rate and OS were evaluated, and iPTH, Ca, and P levels were recorded.
RESULTS: Compared to control group, increased iPTH (P < 0.001), higher Ca (P = 0.003), elevated AST (P = 0.022), and lower Hb (P = 0.049) concentrations were observed in the PTX group at baseline. The 1-year mortality (P < 0.001), 2-year mortality (P < 0.001), and 3-year mortality (P < 0.001) was reduced in PTX group compared to Control group, and PTX was correlated with prolonged OS (P < 0.001). Multivariate Cox's regression analysis further revealed that PTX treatment (P < 0.001, HR = 0.177) was an independent factor for better OS. Moreover, patients in PTX group had decreased iPTH (P < 0.05) and Ca (P < 0.05) levels compared to Control group at M1-M36, while no difference was found in serum P level between the two groups at M1-M36.
CONCLUSION: Parathyroidectomy decreases iPTH and Ca levels, and it associates with favorable survival in elderly hemodialysis patients with severe SHPT.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Parathyroidectomy; elderly; hemodialysis; overall survival; secondary hyperparathyroidism

Mesh:

Substances:

Year:  2018        PMID: 30485538      PMCID: PMC6818588          DOI: 10.1002/jcla.22696

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  13 in total

1.  Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism.

Authors:  Hirotaka Komaba; Masatomo Taniguchi; Atsushi Wada; Kunitoshi Iseki; Yoshiharu Tsubakihara; Masafumi Fukagawa
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

2.  Parathyroidectomy decreases serum intact parathyroid hormone and calcium levels and prolongs overall survival in elderly hemodialysis patients with severe secondary hyperparathyroidism.

Authors:  Jinnan Wan; Wenhuan Li; Yuan Zhong
Journal:  J Clin Lab Anal       Date:  2018-11-28       Impact factor: 2.352

3.  Parathyroidectomy in the elderly: do the benefits outweigh the risks?

Authors:  H Chen; S Parkerson; R Udelsman
Journal:  World J Surg       Date:  1998-06       Impact factor: 3.352

4.  Circulating parathyroid hormone concentration in chronic renal insufficiency.

Authors:  E Reiss; J M Canterbury; A Kanter
Journal:  Arch Intern Med       Date:  1969-10

5.  Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways.

Authors:  Gloria Rashid; Jacques Bernheim; Janice Green; Sydney Benchetrit
Journal:  Am J Physiol Renal Physiol       Date:  2006-12-26

Review 6.  Chronic Kidney Disease.

Authors:  Angela C Webster; Evi V Nagler; Rachael L Morton; Philip Masson
Journal:  Lancet       Date:  2016-11-23       Impact factor: 79.321

7.  Survival following parathyroidectomy among United States dialysis patients.

Authors:  Bryan Kestenbaum; Dennis L Andress; Stephen M Schwartz; Daniel L Gillen; Stephen L Seliger; Paresh R Jadav; Donald J Sherrard; Catherine Stehman-Breen
Journal:  Kidney Int       Date:  2004-11       Impact factor: 10.612

8.  Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Authors:  G A Block; T E Hulbert-Shearon; N W Levin; F K Port
Journal:  Am J Kidney Dis       Date:  1998-04       Impact factor: 8.860

9.  A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia.

Authors:  K Amann; E Ritz; G Wiest; G Klaus; G Mall
Journal:  J Am Soc Nephrol       Date:  1994-04       Impact factor: 10.121

10.  International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data.

Authors:  Elizabeth Hedgeman; Loren Lipworth; Kimberly Lowe; Rajiv Saran; Thy Do; Jon Fryzek
Journal:  Int J Nephrol       Date:  2015-03-31
View more
  5 in total

1.  Parathyroidectomy decreases serum intact parathyroid hormone and calcium levels and prolongs overall survival in elderly hemodialysis patients with severe secondary hyperparathyroidism.

Authors:  Jinnan Wan; Wenhuan Li; Yuan Zhong
Journal:  J Clin Lab Anal       Date:  2018-11-28       Impact factor: 2.352

Review 2.  Management of Secondary Hyperparathyroidism in Chronic Kidney Disease: A Focus on the Elderly.

Authors:  Andrea Galassi; Paola Ciceri; Eliana Fasulo; Stefano Carugo; Giuseppe Cianciolo; Mario Cozzolino
Journal:  Drugs Aging       Date:  2019-10       Impact factor: 3.923

3.  Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.

Authors:  Yi Zhang; Ying Lu; Sheng Feng; Zhoubing Zhan; Huaying Shen
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

4.  The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism.

Authors:  Xiaoer Zhang; Wenxin Xu; Tongyi Huang; Jingzhi Huang; Chunyang Zhang; Yutong Zhang; Xiaoyan Xie; Ming Xu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

5.  Efficacy and safety of radiofrequency ablation versus parathyroidectomy for secondary hyperparathyroidism in dialysis patients: a single-center retrospective study.

Authors:  Mian Ren; Danna Zheng; Juan Wu; Yueming Liu; Chengzhong Peng; Wei Shen; Bo Lin
Journal:  Sci Rep       Date:  2022-06-18       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.